Michael Rader
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Orthopedics and Sports Medicine top 2%
- Surgery top 10%
- Co-authors
- Janet E. BrownKarim FizaziCarsten GoesslHuei WangPiotr MileckiNeal D. ShoreRonaldo DamiãoMichael A. Carducci
- Topics
- Bone health and treatments (7 papers)Blood disorders and treatments (6 papers)Neutropenia and Cancer Infections (6 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Michael Rader
19 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.0k
- Radiology, Nuclear Medicine and Imaging 666
- Orthopedics and Sports Medicine 463
- Surgery 422
Countries citing papers authored by Michael Rader
This map shows the geographic impact of Michael Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rader more than expected).
Fields of papers citing papers by Michael Rader
This network shows the impact of papers produced by Michael Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rader. The network helps show where Michael Rader may publish in the future.
Co-authorship network of co-authors of Michael Rader
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rader. A scholar is included among the top collaborators of Michael Rader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rader. Michael Rader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 109 | |
| 2 | Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsbreakdown → | 420 |
| 3 | 48 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studybreakdown → | 1377 |
| 8 | 2 | |
| 9 | Two Heads Are Better Than One: Collaborative Development of an Online Course Content Template | 1 |
| 10 | 3 | |
| 11 | 53 | |
| 12 | Final results of a large, community-based, prospective study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy | 1 |
| 13 | 41 | |
| 14 | 1 | |
| 15 | 0 | |
| 16 | Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: clinical and economic benefits. | 12 |
| 17 | 2 | |
| 18 | 4 | |
| 19 | 271 | |
| 20 | 15 |
About Michael Rader
Michael Rader is a scholar working on Oncology, Family Practice and Orthopedics and Sports Medicine, having authored 20 papers that have together received 2.4k indexed citations. Recurring topics across this work include Bone health and treatments (7 papers), Blood disorders and treatments (6 papers) and Neutropenia and Cancer Infections (6 papers). The work is most often cited by research in Oncology (1.8k citations), Orthopedics and Sports Medicine (463 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Michael Rader has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Janet E. Brown, Karim Fizazi, Carsten Goessl, Huei Wang, Piotr Milecki, Neal D. Shore, Ronaldo Damião, Michael A. Carducci, Lawrence I. Karsh and Roger Dansey. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.